Skip to content

CIH Stepped Care for Co-occurring Chronic Pain and PTSD

A Pilot Randomized Controlled Trial of CIH Stepped Care for Co-occurring Chronic Pain and PTSD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06219408
Enrollment
60
Registered
2024-01-23
Start date
2026-02-18
Completion date
2027-08-30
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Posttraumatic Stress Disorder

Brief summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, appropriateness, and retention of patient participants of a CIH Stepped Care approach for co-occurring chronic pain and PTSD vs. treatment as usual in two primary care settings (one rural and one urban). Researchers will compare CIH Stepped Care to treatment as usual. Participants will complete assessments at baseline, 3-months, 6-months, and 9-months, and those in the CIH Stepped Care condition will participate in the intervention while also completed assessments every 2-weeks, which helps determine their treatment. We hypothesize that, at 6-months, CIH Stepped Care will be feasible, acceptable, and appropriate (defined by an average of 4/5 on each measure) to patients and clinic employees and result in at least 70% of individuals be retained in each condition (n=21 per condition).

Interventions

BEHAVIORALCIH Stepped Care

CIH Stepped Care is a stepped approach to care delivered by a health coach (e.g., psychologist-in-training or clinical social worker) in-person or remotely (individual person sessions). It is a mindfulness-based and meaning-based stepped care approach for treating co-occurring chronic pain and PTSD that will begin with less intensive treatment (e.g., psychoeducation) and, based on patient response and preference, will be "stepped up" to more intensive treatment when appropriate.

Sponsors

University of Washington
Lead SponsorOTHER
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

To mirror a future large-scale trial, the PI/biostatistician/randomizer will remain masked. An unmasked member of the research team will inform individuals to which group they are randomized and will be available to answer questions about assessments if needed.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

In order to be eligible to participate in this study, clinic employees must meet all of the following criteria: 1. Aged 18 years or older 2. A clinic employee and/or trainee In order to be eligible to participate in this study, patients must meet all of the following criteria: 1. Aged 18 years or older 2. English-speaking 3. A patient at the clinic from which recruitment occurs 4. Endorse chronic pain (defined as experiencing pain on more than half of the days of the past 3-months) 5. Endorse at least moderate pain severity and interference (defined as at least an average of 4 on the PEG) 6. Endorse at least 31 on the PCL-5, in combination with a Criterion A traumatic event. If we have difficulties in recruiting individuals who meet our PTSD diagnosis criteria, we will modify this criteria by removing the requirement of a Criterion A traumatic event, and require a destabilizing life event instead. 4.2

Exclusion criteria

There are no

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Intervention Measure6-monthsFeasibility of intervention; 1-5; higher scores indicate greater feasibility
Acceptability of Intervention Measure6-monthsAcceptability of Intervention; 1-5; higher scores indicate greater acceptability
Appropriateness of Intervention Measure6-monthsAppropriateness of Intervention; 1-5; higher scores indicate greater appropriateness
Participant Retainment6-monthsPercentage of Participants Retained in Intervention Arm

Secondary

MeasureTime frameDescription
PTSD Diagnostic Scale for DSM-5Baseline, 3-, 6-, and 9-monthsPTSD symptoms; 0-80; higher scores indicate more severe PTSD symptoms
Patient Reported Outcome Measurement System - Pain InterferenceBaseline, 3-, 6-, and 9-monthsPain interference; 0-100; higher scores indicate worse pain interference

Countries

United States

Contacts

CONTACTDavid Reed, PhD
davider2@uw.edu206-543-3752
PRINCIPAL_INVESTIGATORDavid Reed, PhD

University of Washington

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026